This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Bob Brown, PhD
CSO and SVP, Research at Dicerna Pharmaceuticals


Bob Brown, Ph.D. joined Dicerna as senior vice president, research in 2008. Prior to joining Dicerna, he had a long career at Genta, where he was vice president, research and technology and had more than 75 issued patents and patent applications.

While at Genta, Bob became one of the only R&D executives in the biotechnology industry to follow a systemically administered oligonucleotide therapeutic (Genasense™) from the research bench through Phase 1, 2 and 3 clinical trials and NDA review. He worked directly with clinicians and study investigators on trial design, execution and interpretation of results. In addition to his roles at Genta, Bob was co-founder and vice president of research and development at Oasis Biosciences.

Bob holds a Ph.D. in molecular biology from the University of California, Berkeley, and B.S. degrees in chemistry and biology from the University of Washington.

Agenda Sessions

  • Dual Dialogue: RNAi Discovery and Development Collaboration Case Study

  • LIVE Q&A SESSION: Dual Dialogue: RNAi Discovery and Development Collaboration Case Study